CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Open-market sale Chief Financial Officer sold 161 shares at $136.64 ($21,999)
- UPLOAD Other SEC-generated Letter
- 8-K Event Other events
- 4 Open-market sale Global Head of R&D sold 660 shares at $142.00 ($93,718)
- 4 Open-market sale President, COO & GM China sold 3,410 shares at $141.99 ($484,202)
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Other events
- UPLOAD Other SEC-generated Letter
- 4 Option exercise Global Head of R&D acquired 1,233,947 shares (option exercise)
- 10-Q Report Quarterly Report
- 4 Open-market sale President, COO & GM China sold 6,725 shares at an average $164.35 ($1,105,276)
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Results of operations · Other events
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations · Other events
- 8-K Event Regulation FD disclosure · Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
Page 30 of 64 · 1,278 filings